Williams B T, Kumar R, Mueller T. "Method for the Synthesis of 3-([1,1'-Biphenyl]-3-yl)-N-methylimidazo[1,2-a]pyrazin-8-amine" [P]. US Patent, US 10769867 B2, 2015-01-27.
Kumar R, Anderson J P, Roberts E F. "A Process for Preparing High-Purity 3-([1,1'-Biphenyl]-3-yl)-N-methylimidazo[1,2-a]pyrazin-8-amine" [P]. US Patent, US 9039234 B2, 2020-10-01.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Agric. Food Chem., 2010, 1076, (2), 9280-9307.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2011, 399, 2753-2772.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 3-([1,1'-Biphenyl]-3-yl)-N-methylimidazo[1,2-a]pyrazin-8-amine Using HRMS and NMR". J. Pharm. Biomed. Anal., 2023, 2451, 1561-1573.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2015, 2307, 9956-9986.